Copyright
©The Author(s) 2022.
World J Gastroenterol. Jan 21, 2022; 28(3): 332-347
Published online Jan 21, 2022. doi: 10.3748/wjg.v28.i3.332
Published online Jan 21, 2022. doi: 10.3748/wjg.v28.i3.332
Ref. | Study design | Cancer stage | EUS-guided intervention | Patients No. | Technical success (%) | Median overall survival (mo) | Pain palliation (patients %) | Serious adverse events, n |
Pishvaian et al[48], 2006 | Prospective | Unresectable | FMP | 7 | 85.7 | -1 | Not reported | 0 |
Choi et al[49], 2014 | Prospective | Unresectable | FMP | 29 | 100 | -1 | Not reported | 12 |
Varadarajulu et al[50], 2010 | Prospective | III (n = 9) | FMP | 9 | 100 | Not reported | Not reported | 0 |
Park et al[51], 2010 | Prospective | III (n = 57) | FMP | 57 | 94 | -1 | Not reported | 0 |
Sanders et al[52], 2010 | Prospective | III (n = 36); Recurrent (n = 15) | FMP | 51 | 90 | -1 | Not reported | 12 |
Dávila et al[53], 2014 | Prospective | II (n = 1); III (n = 22) | FMP | 23 | 100 | -1 | Not reported | 0 |
Khashab et al[54], 2012 | Retrospective | III (n = 39) | FMP | 39 | 100 | -1 | Not reported | 0 |
Sun et al[57], 2012 | Prospective | III (n = 8) | Brachytherapy | 8 | 100 | 8.3 | 50 at week 33 | 0 |
Sun et al[58], 2006 | Prospective | III (n = 8); IV (n = 7) | Brachytherapy | 15 | 100 | 10.6 | 30 at week 42 | 33 |
Jin et al[59], 2008 | Prospective | II (n = 4); III (n = 10); IV (n = 8) | Brachytherapy | 22 | 100 | 9 | 81.8 at week 1 | 0 |
Sun et al[60], 2017 | Retrospective | III (n = 18); IV (n = 24) | Brachytherapy | 42 | 100 | 9 | Not reported | 0 |
Wiersema et al[62], 1996 | Prospective | Unresectable | CPN | 29 | 100 | Not reported | 86 at week 2; 84 at week 4; 79 at week 8; 88 at week 12 | 0 |
Levy et al[64], 2019 | Prospective | II (n = 2); III (n = 27); IV (n = 31) | CPN | 60 | 100 | 10.46 | 40.4 at week 12 | 0 |
Seicean et al[65], 2013 | Prospective | Unresectable | CPN | 32 | 100 | Not reported | 75 at week 2 | 0 |
Facciorusso et al[31], 2017 | Prospective | III (n = 48); IV (n = 10) | CPN | 58 | 100 | 6.5 | 70.6 at week 2 | 0 |
- Citation: Sbeit W, Napoléon B, Khoury T. Endoscopic ultrasound role in pancreatic adenocarcinoma treatment: A review focusing on technical success, safety and efficacy. World J Gastroenterol 2022; 28(3): 332-347
- URL: https://www.wjgnet.com/1007-9327/full/v28/i3/332.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i3.332